![Adderall and amoxicillin shortages raise questions about transparency and accountability in Big Pharma Adderall and amoxicillin shortages raise questions about transparency and accountability in Big Pharma](/var/ezflow_site/storage/images/iol-home/about-informs/news-room/o.r.-and-analytics-in-the-news/adderall-and-amoxicillin-shortages-raise-questions-about-transparency-and-accountability-in-big-pharma/4415744-1-eng-US/Adderall-and-amoxicillin-shortages-raise-questions-about-transparency-and-accountability-in-Big-Pharma_newslargethumb.jpg)
Adderall and amoxicillin shortages raise questions about transparency and accountability in Big Pharma
Consumers are at the mercy of drug companies when it comes to learning about what is causing the shortages, and how and when they might be resolved.